Endometriosis Trial, Recruiting NCT06020482 Sponsor: General University Hospital, Prague Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06020482
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 45 years old
  • You are willing and able to sign a consent form agreeing to take part in the study
  • You have not used any hormonal treatments (such as birth control pills or hormone therapy) in the 3 months before the planned procedure

For Group A specifically:

  • You have been diagnosed with endometriosis, confirmed through a keyhole surgery (laparoscopy) and a tissue sample test (biopsy)

For Group B specifically:

  • You do not have endometriosis
  • You are already scheduled to have a planned keyhole surgery (laparoscopy) or a procedure to look inside the womb (hysteroscopy) at the trial site for another non-cancer-related reason
  • You have been confirmed to not have any cancerous disease

Who may not be able to join:

  • You are not willing or able to sign the consent form agreeing to take part
  • You do not meet the required criteria at the time of your surgery (confirm with trial site)
  • You are younger than 18 years old or older than 45 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
General University Hospital, Prague
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Molecular markers of fibrosis of single types of endometriosis and their use in predicting disease severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov